UA93202C2 - Полиморфная форма кристаллической гемикальциевой соли аторвастатина - Google Patents

Полиморфная форма кристаллической гемикальциевой соли аторвастатина

Info

Publication number: UA93202C2
Authority: UA; Ukraine
Prior art keywords: polymorph form; atorvastatin hemicalcium; hemicalcium salt; crystalline atorvastatin; salt polymorph
Prior art date: 2005-04-08

Application number

UAA200712404A

Other languages

English (en)

Ukrainian (uk)

Inventor

Йожеф Баркоци

Надь Петер Котай

Дьюла Симиг

Джудит Челеняк

Жужанна Сент-Киральи

Ференц Барта

Зольтан Катона

Донат Дьйорди Верецкейне

Калман Наги

Норберт Немет

Дьйордь Ружич

Original Assignee

Эгиш Дьёдьсердьяр Нильваношан Мюкёдо Ресвеньтаршашаг

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-04-08

Filing date

2006-04-07

Publication date

2011-01-25

2006-04-07 Application filed by Эгиш Дьёдьсердьяр Нильваношан Мюкёдо Ресвеньтаршашаг filed Critical Эгиш Дьёдьсердьяр Нильваношан Мюкёдо Ресвеньтаршашаг

2011-01-25 Publication of UA93202C2 publication Critical patent/UA93202C2/ru

Links

FQCKMBLVYCEXJB-MNSAWQCASA-L atorvastatin calcium Chemical compound [Ca+2].C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC([O-])=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1.C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC([O-])=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 FQCKMBLVYCEXJB-MNSAWQCASA-L 0.000 title abstract 2
238000002360 preparation method Methods 0.000 abstract 3
229940126601 medicinal product Drugs 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1

Landscapes

Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyrrole Compounds (AREA)

UAA200712404A 2005-04-08 2006-04-07 Полиморфная форма кристаллической гемикальциевой соли аторвастатина UA93202C2 (ru)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
HU0500370A HU0500370D0 (en)	2005-04-08	2005-04-08	New crystalline atorvastatin hemicalcium polimorph

Publications (1)

Publication Number	Publication Date
UA93202C2 true UA93202C2 (ru)	2011-01-25

Family

ID=89985918

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
UAA200712404A UA93202C2 (ru)	2005-04-08	2006-04-07	Полиморфная форма кристаллической гемикальциевой соли аторвастатина

Country Status (3)

Country	Link
CN (1)	CN101213171A (ru)
HU (1)	HU0500370D0 (ru)
UA (1)	UA93202C2 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN104945300B (zh) *	2015-06-17	2017-05-10	北京嘉林药业股份有限公司	一种ⅰ型阿托伐他汀钙的纯化方法

2005
- 2005-04-08 HU HU0500370A patent/HU0500370D0/hu unknown
2006
- 2006-04-07 CN CNA2006800177166A patent/CN101213171A/zh active Pending
- 2006-04-07 UA UAA200712404A patent/UA93202C2/ru unknown

Also Published As

Publication number	Publication date
HU0500370D0 (en)	2005-05-30
CN101213171A (zh)	2008-07-02

Similar Documents

Publication	Publication Date	Title
YU56803A (sh)	2006-05-25	Pripremanje nekristalinskog atorvastatin-kalcijuma
PL396343A1 (pl)	2012-01-16	Preparat farmaceutyczny zawierający sól wapniową atorwarstatyny, sposób wytwarzania tego preparatu i jego zastosowanie do leczenia hipercholesterolemii i hiperlipidemii
TWI319396B (en)	2010-01-11	Crystalline forms of [r-(r,r)]-2-(4-fluorophenyl)-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt (2:1)
YU36802A (sh)	2005-09-19	Postupak za dobijanje amorfnog atorvastatina
HUP9901687A2 (hu)	1999-10-28	Kristályos (III) formájú (R-(R,R)-2-(4-fluor-fenil)-béta,delta-dihidroxi-5-(1-metil-etil)-3-fenil-4-((fenil-amino)-karbonil)-1H-pirrol-1-heptánsav hemi kálcium-só (Atorvastatin) és ezt a vegyületet tartalmazó gyógyszerkészítmények
NZ312907A (en)	2000-12-22	Crystalline [r-(r,r)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl
MXPA04000889A (es)	2004-06-03	Formas cristalinas vi y vii de atorvastatina calcica.
EP2682387A3 (en)	2014-06-18	C7-fluoro substituted tetracycline compounds
CA2406266A1 (en)	2001-10-25	A pyridine-1-oxide derivative, and process for its transformation into pharmaceutically effective compounds
ZA201003380B (en)	2011-12-28	Improved pharmaceutical composition containing a pyrrolidone anticonvulsant agent and methhod for the preparation thereof
NO20075721L (no)	2008-01-04	New crystalline atorvastatin hemicalcium salt polymorph form
WO2004050618A3 (en)	2004-07-15	Crystalline form f of atorvastatin hemi-calcium salt
WO2009007856A3 (en)	2009-06-25	Novel polymorph of atorvastatin calcium and use thereof for the preparation of amorphous atorvastatin calcium
MY148499A (en)	2013-04-30	Substituted pyrrole derivatives
WO2010038948A3 (en)	2010-06-24	Arylpiperazine-containing pyrrole 3-carboxamide derivatives for treating depressive disorders
UA93202C2 (ru)	2011-01-25	Полиморфная форма кристаллической гемикальциевой соли аторвастатина
Zhou et al.	2015	N-Oxide derivatives of 3-(3-pyridyl)-2-phosphonopropanoic acids as potential inhibitors of Rab geranylgeranylation
WO2005123670A3 (en)	2006-02-09	Crystalline form of a substituted pyrrolidine compound
WO2009054693A3 (en)	2009-06-18	Process for the preparation of atorvastatin
EA200901205A1 (ru)	2010-02-26	Фармацевтическая композиция, содержащая соль розиглитазона
WO2009000286A8 (en)	2010-02-25	Improved pharmaceutical formulation containing an hmg-coa reductase inhibitor and method for the preparation thereof
CL2009001050A1 (es)	2010-05-14	Proceso de preparacion de una composicion farmaceutica que comprende obtener la sal hemicalcica del acido [r-(r,r)]-2-(4-fluorofenil)-beta,delta-dihidroxi-5-(1-metiletil)-3-fenil-4-[(fenilamino)carbonil]-1h-pirrol-1-heptanoico y adicionar un portador farmaceuticamente aceptable a dicho compuesto (divisional de la solicitud 1301-03).
WO2016142954A3 (en)	2016-11-03	IMPROVED PROCESS FOR THE PREPARATION OF [3R,5R]-2-FLUOROPHENYL-β,δ- DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(2-HYDROXYPHENYLAMINO)- CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID, SODIUM SALT
DE602005016711D1 (de)	2009-10-29	Isoxazolsäure-derivat zur linderung neuropathischer schmerzen
HK1119686A (en)	2009-03-13	Process for preparation of (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt